Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities
Net loss	$ (6,293,319)	$ (4,442,988)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	314,441	349,388
Amortization of intangible assets	369,021	380,388
Stock-based compensation	413,610	644,640
Equity in loss of investee company	533,113	58,710
Changes in assets and liabilities
Accounts receivable	(690,922)	(189,616)
Inventories	67,723	(1,151,633)
Prepaids and other current assets	(712,359)	(87,896)
Refundable income taxes	(79,847)	47,450
Accounts payable	(562,705)	904,531
Accrued compensation and benefits	(203,529)	(169,134)
Accrued expenses	(69,222)	(206,541)
Customer deposits	286,957	308,516
Net cash used in operating activities	(6,627,038)	(3,554,185)
Cash flows from investing activities
Expenditures for property and equipment	(91,690)	(1,307,927)
Investment in investee company		(1,640,728)
Deposits of restricted cash	(310,000)
Net cash used in investing activities	(401,690)	(2,948,655)
Cash flows from financing activities
Repayments of bank loans and notes payable	(283,495)	(151,867)
Proceeds from issuance of Series A preferred stock		2,197,240
Proceeds from issuance of Common Stock	1,744,688	1,887,398
Common stock issuance costs	(143,009)	(176,934)
Proceeds from noncontrolling interest	5,500	1,546,062
Net cash provided by financing activities	1,323,684	5,301,899
Effect of exchange rate changes on cash and cash equivalents	627	(29,111)
Net decrease in cash and cash equivalents	(5,704,417)	(1,230,052)
Cash and cash equivalents - beginning of period	7,823,217	2,910,595
Cash and cash equivalents - end of period	2,118,800	1,680,543
Cash paid for interest	93,210	105,451
Cash received for income tax credit		223,703
Supplemental non-cash investing and financing activities:
Issuance of common stock for discounted notes receivable		$ 2,187,330